ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TELO vs SDEV // ALTMAN Z-SCORE & DEBT/EQUITY

Telomir Pharmaceuticals Inc. (NASDAQ) VS. Stablecoin Development Corporation (NYSE) • 15-METRIC TALLY: TELO 3 — SDEV 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELO VS. SDEV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TELO SDEV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.19% -10.68% +5.49 TELO /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 6.10% -6.10 SDEV /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 TELO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.4 43.9 -16.50 SDEV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.4M $67.3M $153.0K TELO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TELO REV SDEV REV TELO GROSS % SDEV GROSS % TELO FCF SDEV FCF
FY 2025 $3.1M $23.6M — — -$3.7M -$8.4M
FY 2024 $556.1K $9.8M — 66.3% -$5.1M -$7.5M
FY 2023 $58.8M $11.5M — — -$3.9M -$4.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TELO // BETA —
SDEV // BETA —